|
1）Kuller LH, Ockene J, Meilahn E. Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Epidemiol. 1990; 132: 265-74
|
|
|
|
2）Turner MC, Chen Y, Krewski D. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007; 176: 285-90
|
|
|
|
|
3）Spitz MR, Wei Q, Dong Q. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003; 12: 689-98
|
|
|
|
|
|
4）de Torres JP, Marín JM, Casanova C, et al. Lung cancer in patients with COPD: Incidence and predicting factors. Am J Respir Crit Care Med. 2011; 184: 913-19
|
|
|
|
|
|
5）Sekine Y, Yamada Y, Chiyo M, et al. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg. 2007; 84: 946-50
|
|
|
|
|
|
6）Lourenço RV, Klimek MF, Borowski CJ. Deposition and clearance of 2 micron particles in the tracheobronchial tree of normal subjects-smokers and nonsmokers. J Clin Invest. 1971; 50: 1411-20
|
|
|
|
|
|
7）Cerda S, Weitzman SA. Influence of oxygen radical injury on DNA methylation. Mutat Res. 1997; 386: 141-52
|
|
|
|
|
|
8）Dialyna IA, Miyakis S, Georgatou N. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk. Oncol Rep. 2003; 10: 1829-35
|
|
|
|
|
|
9）Galaris D, Evangelou A. The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit Rev Oncol Hematol. 2002; 42: 93-103
|
|
|
|
|
|
10）Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol. 2009; 9: 375-83
|
|
|
|
|
|
11）Global initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD Update 2010. http://www.goldcopd.org/Guidelineitem.asp?l1＝2&l2＝1&intId＝989 updated: July 23 2011
|
|
|
|
|
|
12）Houghton AM, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nat Med. 2008; 14: 1023-4
|
|
|
|
|
|
13）Brody JS, Spira A. State of the art. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc. 2006; 3: 535-7
|
|
|
|
|
|
14）Komarova EA, Krivokrysenko V, Wang K. p53 is a suppressor of inflammatory response in mice. FASEB J. 2005; 19: 1030-2
|
|
|
|
|
|
15）Sekine Y, Katsura H, Koh E, et al. Early detection of COPD is important for lung cancer surveillance. Eur Resp J. 2012; 39: 1230-40
|
|
|
|
|
|
16）Fukuchi Y, Nishimura M, Ichinose M. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004; 9: 458-65
|
|
|
|
|
|
17）Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982; 33: 379-87
|
|
|
|
|